These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32311128)

  • 1. Budgets versus Bans: How U.S. Law Restricts Germline Gene Editing.
    Johnston J
    Hastings Cent Rep; 2020 Mar; 50(2):4-5. PubMed ID: 32311128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiments that led to the first gene-edited babies: the ethical failings and the urgent need for better governance.
    Li JR; Walker S; Nie JB; Zhang XQ
    J Zhejiang Univ Sci B; 2019 Jan.; 20(1):32-38. PubMed ID: 30614228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR'd babies: human germline genome editing in the 'He Jiankui affair'.
    Greely HT
    J Law Biosci; 2019 Oct; 6(1):111-183. PubMed ID: 31666967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR babies: a view from the centre of the storm.
    Lovell-Badge R
    Development; 2019 Feb; 146(3):. PubMed ID: 30728161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Developments in the Regulation of Heritable Human Genome Editing.
    Soni S
    J Bioeth Inq; 2024 Mar; 21(1):15-18. PubMed ID: 38568398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-edited babies: What went wrong and what could go wrong.
    Wang H; Yang H
    PLoS Biol; 2019 Apr; 17(4):e3000224. PubMed ID: 31039144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imperatives of Governance: Human Genome Editing and the Problem of Progress.
    Hurlbut JB
    Perspect Biol Med; 2020; 63(1):177-194. PubMed ID: 32063595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realigning gene editing with clinical research ethics: What the "CRISPR Twins" debacle means for Chinese and international research ethics governance.
    Kleiderman E; Ogbogu U
    Account Res; 2019 May; 26(4):257-264. PubMed ID: 31068009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legal reflections on the case of genome-edited babies.
    Liu S
    Glob Health Res Policy; 2020; 5():24. PubMed ID: 32435694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation.
    Doxzen K; Halpern J
    Perspect Biol Med; 2020; 63(1):44-53. PubMed ID: 32063585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable Genome Editing and the Downsides of a Global Moratorium.
    Macintosh KL
    CRISPR J; 2019 Oct; 2(5):272-279. PubMed ID: 31599680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. He Jiankui´s gene-editing experiment and the non-identity problem.
    Alonso M; Savulescu J
    Bioethics; 2021 Jul; 35(6):563-573. PubMed ID: 33951203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline Modification and Policymaking: The Relationship between Mitochondrial Replacement and Gene Editing.
    Cussins J; Lowthorp L
    New Bioeth; 2018 Apr; 24(1):74-94. PubMed ID: 29529982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who Goes First? Deaf People and CRISPR Germline Editing.
    Padden C; Humphries J
    Perspect Biol Med; 2020; 63(1):54-65. PubMed ID: 32063586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making sense of it all: Ethical reflections on the conditions surrounding the first genome-edited babies.
    Chen Q; Ma Y; Labude M; Schaefer GO; Xafis V; Mills P
    Wellcome Open Res; 2020; 5():216. PubMed ID: 34395922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsible governance of human germline genome editing in China†.
    Peng Y; Lv J; Ding L; Gong X; Zhou Q
    Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Governing Human Germline Editing Through Patent Law.
    Sherkow JS; Adashi EY; Cohen IG
    JAMA; 2021 Sep; 326(12):1149-1150. PubMed ID: 34459849
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical application of gene editing: ethical and social issues.
    Ormond KE; Bombard Y; Bonham VL; Hoffman-Andrews L; Howard H; Isasi R; Musunuru K; Riggan KA; Michie M; Allyse M
    Per Med; 2019 Jul; 16(4):337-350. PubMed ID: 31331245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking responsibility, making irresponsibility: Controversies in human gene editing.
    Meyer M
    Soc Stud Sci; 2022 Feb; 52(1):127-143. PubMed ID: 34219564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.